What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12916-019-1307-8

PubMed Identifier: 30979373

Publication URI: http://europepmc.org/abstract/MED/30979373

Type: Journal Article/Review

Volume: 17

Parent Publication: BMC medicine

Issue: 1

ISSN: 1741-7015